Genematrix Inc.   Report issue

For profit Phase 4
Founded: Seongnam Korea, Republic of (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2007
NCT00531167
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now